Activaero appoints chief business officer

Christian Pangratz takes the role

Activaero, a German leader in controlled breathing inhalation technologies and therapeutics, has appointed Christian Pangratz as chief business officer.

Pangratz joins Activaero from Nektar Therapeutics, in San Francisco, US, where he recently served as executive director of business development. He brings to Activaero 20 years of life science experience.

Pangratz will join the Activaero management team and lead all business development, marketing and alliance management activities. He replaces Henrik Luessen, who has decided to focus on his own consultancy firm, but will continue to support Activaero’s business development team on a part-time basis.

You may also like

Finance

Vectura Group to buy Activaero for £108m

Will enable Vectura to build a therapeutic specialist in airways diseases
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Taking biologic therapies out of the clinic

Taking biologic therapies out of the clinic

How larger autoinjectors are changing drug delivery device testing
Media
Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in IDC’s 2026 assessment of life sciences R&D technology providers, with case studies from GSK and AstraZeneca highlighting the potential of digital twins and process modelling to accelerate development and manufacturing
Finance
Viral vector CDMO VintaBio’s Philadelphia facility and IP up for sale

Viral vector CDMO VintaBio’s Philadelphia facility and IP up for sale

VintaBio’s assignee is seeking bids for its cGMP facility, equipment and proprietary AAV technology as gene therapy contract manufacturers face overcapacity
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing

How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing

Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Ingredients
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
Manufacturing
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
Subscribe now